BLOOD LEVELS OF DRUG AT EQUILIBRIUM STATE AFTER MULTIPLE DOSING

[1] BINNS TB, 1964, ABSORPTION DISTRIBUT

[2] BOXER GE, 1948, J PHARMACOL EXP THER, V92, P226

[3] BUENGER P, 1961, ARZNEIMITTELFORSCH, V11, P247

[4] BURNS JJ, 1953, J PHARMACOL EXP THER, V109, P346

[5] BUTLER TC, 1954, J PHARMACOL EXP THER, V111, P425

[6] FACTORS INFLUENCING PLASMA SALICYLATE CONCENTRATION + URINARY SALICYLATE EXCRETION AFTER ORAL DOSAGE WITH ASPRIIN [J]. BIOCHEMICAL PHARMACOLOGY, 1964, 13 (05) : 767 - &

[7] DEJONGH SE, 1950, ACTA PHYSIOL PHARM N, V1, P237

[8] DOMINGUEZ R, 1945, P SOC EXP BIOL MED, V60, P173, DOI 10.3181/00379727-60-15130

[9] Dost FH., 1953, BLUTSPIEGEL KINETIK

[10] DOSAGE SCHEDULE AND PHARMACOKINETICS IN CHEMOTHERAPY [J]. JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1960, 49 (05): : 311 - 313

[1] BINNS TB, 1964, ABSORPTION DISTRIBUT

[2] BOXER GE, 1948, J PHARMACOL EXP THER, V92, P226

[3] BUENGER P, 1961, ARZNEIMITTELFORSCH, V11, P247

[4] BURNS JJ, 1953, J PHARMACOL EXP THER, V109, P346

[5] BUTLER TC, 1954, J PHARMACOL EXP THER, V111, P425

[6] FACTORS INFLUENCING PLASMA SALICYLATE CONCENTRATION + URINARY SALICYLATE EXCRETION AFTER ORAL DOSAGE WITH ASPRIIN [J]. BIOCHEMICAL PHARMACOLOGY, 1964, 13 (05) : 767 - &

[7] DEJONGH SE, 1950, ACTA PHYSIOL PHARM N, V1, P237

[8] DOMINGUEZ R, 1945, P SOC EXP BIOL MED, V60, P173, DOI 10.3181/00379727-60-15130

[9] Dost FH., 1953, BLUTSPIEGEL KINETIK

[10] DOSAGE SCHEDULE AND PHARMACOKINETICS IN CHEMOTHERAPY [J]. JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1960, 49 (05): : 311 - 313